Summary –
Amidst tariff tensions with the United States, Europe has created a major opportunity for the Indian pharmaceutical industry. CDSCO has granted approval to three Indian companies for API exports to the European Union. This will increase the competitiveness of Indian generic drugs, accelerate exports, and strengthen India’s share in the European market. However, companies will have to continuously comply with strict quality standards.
…………………………………………………………..
Details –
Amidst tariff tensions with the United States, Europe has opened its doors for Indian pharmaceutical companies. The Central Drugs Standard Control Organization (CDSCO) has granted written approval to several Indian companies for the export of active pharmaceutical ingredients (APIs), the raw materials for medicines, to the European Union (EU). This means that these companies will now be able to export APIs used in the treatment of cancer, antibiotics, and other serious diseases while complying with Europe’s strict quality standards.
……………..
Under What Conditions Did Indian Companies Get Approval
…………………………………………………………
CDSCO has clarified that even after receiving approval, all companies must continuously comply with quality standards. If any discrepancy is found during inspection, the quality of the medicine is found to be below standards, or any irregularity comes to light in the reports of local or international regulators, it must be reported within seven days. In case of violation of rules, this approval can be immediately suspended or canceled.
……………
What Will India and Europe Benefit from This Agreement
………………………………………………………….
With the elimination of taxes on medicines and medical devices, Indian generic drugs will become cheaper and more competitive in Europe. At the same time, administrative costs will decrease, and with the simplification of rules, the process of getting medicines approved in Europe will also become faster than before.
……….
Which Indian Companies Got Approval for Export to Europe
……………………………………………………………
Companies that have received approval for API export to the European Union include Honor Lab Limited (Telangana), Ravi Biolife Private Limited (Maharashtra), and Unimax Chemicals Private Limited (Maharashtra).
About the Author
